When you look at the CDC list and what PBT2 can kill, it is very likely, that PBT2 will solve ( at this time ) the biggest part of the problem, I believe that PBT2 can kill almost all previously antibiotic-resistant bacteria (perhaps Tbc and candida excluded).
Difficult to think that the antibiotic resistance fund could play a big role in the deal with its $ 1B. Real BIG Pharma, with its billions, is needed. Just my simple opinion! What are we waiting for?
Even the goal to find 2-4 new antibiotics in 10 years is stupid after PBT2 has been invented in killing bacteria because it itself can be counted to present at least 10 new drugs. PBT2 may work in Tbc, but most likely not in candida. So candida can be left for the fund.
Antibiotic-resistant problem: Urgent, serious and concerns of CDC (USA), page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.233K | 885.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 90514720 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20531083 | 18 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 500000 | ||
| Last updated 15.07pm 14/06/2024 ? | |||||
| ATH (ASX) Chart |